Insulin Patch Pumps: Their Development and Future in Closed-Loop Systems

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Diabetes Technology & Therapeutics

• Publication date

  2010-06-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1089/dia.2010.0016PMID 20515308PMCID PMC2924780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Artificial pancreas: an emerging approach to treat Type 1 diabetes

  2009cited by this paper
• Is an Automatic Pump Suspension Feature Safe for Children with Type 1 Diabetes? An Exploratory Analysis with a Closed-Loop System

  2009cited by this paper
• In Silico Evaluation Platform for Artificial Pancreatic β-Cell Development—A Dynamic Simulator for Closed-Loop Control with Hardware-in-the-Loop

  2009cited by this paper
• Can We Really Close the Loop and How Soon? Accelerating the Availability of an Artificial Pancreas: A Roadmap to Better Diabetes Outcomes

  2009cited by this paper
• Beliefs about insulin as a predictor of fear of hypoglycaemia

  2009cited by this paper
• Artificial pancreas may soon be a reality.

  2009cited by this paper
• Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?

  2009cited by this paper
• Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier

  2009cited by this paper
• Type 1 Diabetes Among Adolescents

  2009cited by this paper
• In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes

  2009influential reference
• An Improved PID Switching Control Strategy for Type 1 Diabetes

  2008cited by this paper
• Bolus Calculator: A Review of Four “Smart” Insulin Pumps

  2008cited by this paper
• Sensor-augmented pump therapy in type 1 diabetes

  2008cited by this paper
• Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

  2008cited by this paper
• The future of continuous glucose monitoring: closed loop.

  2008cited by this paper
• An improved PID switching control strategy for type 1 diabetes.

  2008cited by this paper
• Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas

  2008cited by this paper
• Model Predictive Control of Type 1 Diabetes: An in Silico Trial

  2007cited by this paper
• Linear Quadratic Gaussian-Based Closed-Loop Control of Type 1 Diabetes

  2007cited by this paper
• Meal Simulation Model of the Glucose-Insulin System

  2007cited by this paper
• Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion

  2007cited by this paper
• Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes

  2006cited by this paper
• A System Model of Oral Glucose Absorption: Validation on Gold Standard Data

  2006cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• A Critical Assessment of Algorithms and Challenges in the Development of a Closed-Loop Artificial Pancreas

  2005cited by this paper
• Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection

  2004cited by this paper
• Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes.

  2004cited by this paper
• Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use.

  2003cited by this paper
• Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

  2000cited by this paper
• The British Diabetic Association Cohort Study, I: all‐cause mortality in patients with insulin‐treated diabetes mellitus

  1999cited by this paper
• The British Diabetic Association Cohort Study, II: cause‐specific mortality in patients with insulin‐treated diabetes mellitus

  1999cited by this paper
• Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group.

  1997cited by this paper

• New Dosage Form of Insulin: Review Article

  2024cites this paper
• The Internet of Bio-Nano Things with Insulin-Glucose, Security and Research Challenges: A Survey

  2024cites this paper
• Nanoformulation mediated transdermal delivery of anti-diabetic drugs: An updated review

  2023cites this paper
• Patch Pumps: What are the advantages for people with diabetes?

  2022cites this paper
• Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches

  2022cites this paper
• Performance Evaluation of LQR Method for Motor Employed in Medical Grade Infusion Pump

  2021cites this paper
• REVIEW: Nanobiotechnology: Cradle for revolution in drug carrier systems.

  2021cites this paper
• Piezoelectric titanium based microfluidic pump and valves for implantable medical applications

  2021cites this paper
• Intelligent automated drug administration and therapy: future of healthcare

  2021cites this paper
• Piezoelectric Silicon Micropump for Drug Delivery Applications

  2021cites this paper
• A Systematic Review of Bio-Cyber Interface Technologies and Security Issues for Internet of Bio-Nano Things

  2021cites this paper
• Prediction of Speed for Smart Insulin Pump Utilizing Adaptive Neuro-fuzzy Inference System and ANN

  2021cites this paper
• RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020

  2020cites this paper
• RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020

  2020cites this paper
• Non-invasive strategies for protein drug delivery: Oral, transdermal, and pulmonary

  2020cites this paper
• Clinical Opportunities for Continuous Biosensing and Closed-Loop Therapies

  2020cites this paper
• A Review on Bioengineering Approaches to Insulin Delivery: A Pharmaceutical and Engineering Perspective.

  2019cites this paper
• Pharmacodynamic Evaluation: Diabetic Methodologies

  2019cites this paper
• Thermoresponsive gating membranes embedded with liquid crystal(s) for pulsatile transdermal drug delivery: An overview and perspectives.

  2019cites this paper
• Newer therapeutic approaches towards the management of diabetes mellitus: an update.

  2019cites this paper
• Comparative Dose Accuracy of Durable and Patch Insulin Pumps Under Laboratory Conditions

  2019cites this paper
• A novel strategy of nanotized herbal drugs and their delivery in the treatment of diabetes: Present status and future prospects

  2019cites this paper
• Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen

  2019cites this paper
• A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade.

  2019cites this paper
• Risk and Relevance of Insulin Pump Therapy in the Aetiology of Ketoacidosis in People with Type 1 Diabetes.

  2018cites this paper
• Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch

  2018cites this paper
• Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides.

  2018cites this paper
• Patch Pumps: Are They All the Same?

  2018cites this paper
• Expression of circulating Microrna’s (Mirnas) in blood of mixed ancestry subjects with glucose intolerance

  2018cites this paper
• Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes

  2017cites this paper
• A Review of Safety and Design Requirements of the Artificial Pancreas

  2016cites this paper
• A Laminar Flow-Based Microfluidic Tesla Pump via Lithography Enabled 3D Printing

  2016cites this paper
• Advances in Devices for Insulin Delivery and Glucose Monitoring

  2016cites this paper
• From Insulin Pumps to Artificial Pancreas: Indian Experience over 12 years

  2016cites this paper
• Comparing Normal Insulin Physiology and Insulin Dysfunction in Diabetes Mellitus : Constructing Optimal Insulin-Based Regimens

  2016cites this paper
• A Comparative Pulse Accuracy Study of Two Commercially Available Patch Insulin Infusion Pumps

  2016cites this paper
• Research Update—Closed Loop/Artificial Pancreas

  2016cites this paper
• Breaching the skin barrier through temperature modulations.

  2015cites this paper
• Durability of the Continuous Subcutaneous Insulin Infusion (CSII) Patch Adhesive

  2015cites this paper
• Intelligent Insulin Pens A luxurious instrument or an essential gadget ? — A qualitative study

  2015cites this paper
• Intelligent insulin pens: A promising technology toward smart diabetic management systems

  2015cites this paper
• Ubiquitous Healthcare Systems : Improving the Management of Diabetes Mellitus through the Ubiquitous Technologies

  2015cites this paper
• Skin complication of insulin pump therapy - contact dermatitis from patch pump adhesive

  2014cites this paper
• High precision innovative micropump for artificial pancreas

  2014cites this paper
• Accuracy of a New Patch Pump Based on a Microelectromechanical System (MEMS) Compared to Other Commercially Available Insulin Pumps

  2014cites this paper
• Closed-Loop System in the Management of Diabetes: Past, Present, and Future

  2014cites this paper
• Understanding key parameters affecting needle-free skin penetration by a parenteral drug delivery system

  2013cites this paper
• New technologies in insulin delivery

  2013cites this paper
• Premeal injection of rapid acting insulin reduces postprandial glycaemic excursions in type 1 diabetes

  2013cites this paper
• Modeling an artificial pancreas using retarded impulsive differential equation

  2013cites this paper
• Patch Pump Versus Conventional Pump: Postprandial Glycemic Excursions and the Influence of Wear Time

  2013cites this paper
• An inverse feedback fuzzy state space modeling (FFSSM) for insulin-glucose regulatory system in humans

  2013cites this paper
• Clinical utility of insulin and insulin analogs

  2013cites this paper
• Role of Insulin in the Type 2 Diabetes Therapy: Past, Present and Future

  2013cites this paper
• Insulin therapy in type 2 diabetes mellitus.

  2012cites this paper
• BioMEMs for drug delivery applications

  2012cites this paper
• New technologies for diabetes: a review of the present and the future

  2012cites this paper
• Emerging diabetes therapies and technologies.

  2012cites this paper
• Challenges and recent progress in the development of a closed-loop artificial pancreas

  2012cites this paper
• Management of diabetes mellitus: is the pump mightier than the pen?

  2012cites this paper
• A fermentation-powered thermopneumatic pump for biomedical applications.

  2012cites this paper
• Novel non-invasive methods of insulin delivery

  2012cites this paper
• Intensive insulin therapy in patients with type 1 diabetes mellitus.

  2012cites this paper
• Closed-loop insulin delivery in adults with type 1 diabetes

  2012cites this paper
• A Closed-Loop Control Strategy for Glucose Control in Artificial Pancreas Systems

  2012cites this paper
• New-generation diabetes management: glucose sensor-augmented insulin pump therapy

  2011cites this paper
• Insulin Preparations with Prolonged Effect

  2011cites this paper
• Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.

  2011cites this paper
• Stabilized Glucagon Formulation for Bihormonal Pump Use

  2010cites this paper
• Impact of Insulin Delivery Devices in Diabetes Care

  2010cites this paper
• Use of Sensors in the Treatment and Follow-up of Patients with Diabetes Mellitus

  2010cites this paper